Bowen Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- Extracellular vesicles in disease 14
- Ubiquitin and proteasome pathways 13
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 11
-
- Cancer-related molecular mechanisms research 13
- Cancer, Hypoxia, and Metabolism 11
- Co-authors
- Canhua Huang (36 shared papers)Edouard C. Nice (29 shared papers)Zhao Huang (14 shared papers)Siyuan Qin (19 shared papers)Jing Tang (2 shared papers)Jingwen Jiang (13 shared papers)Zhihan Wang (3 shared papers)Mengtong Xu (1 shared paper)
- Journals
- Small (5 papers)Cell Death and Disease (3 papers)Cancer Letters (3 papers)Drug Resistance Updates (3 papers)Journal of Controlled Release (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Bowen Li
153 papers receiving 3.7k citations
Bowen Li's Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 767
- Molecular Biology 1.8k
- Immunology 404
- Oncology 473
- Microbiology 107
Countries citing papers authored by Bowen Li
This map shows the geographic impact of Bowen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowen Li more than expected).
Fields of papers citing papers by Bowen Li
This network shows the impact of papers produced by Bowen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowen Li. The network helps show where Bowen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bowen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral squamous cell carcinomas: state of the field and emerging directions Hit paper breakdown → | 2023 | 392 |
| 2 | Drug-induced oxidative stress in cancer treatments: Angel or devil? Hit paper breakdown → | 2023 | 144 |
| 3 | 2020 | 139 | |
| 4 | Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment Hit paper breakdown → | 2023 | 138 |
| 5 | 2022 | 131 | |
| 6 | 2019 | 114 | |
| 7 | 2015 | 104 | |
| 8 | 2022 | 94 | |
| 9 | 2020 | 83 | |
| 10 | 2019 | 72 | |
| 11 | 2021 | 68 | |
| 12 | 2021 | 63 | |
| 13 | 2017 | 60 | |
| 14 | 2023 | 56 | |
| 15 | 2023 | 52 | |
| 16 | New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies. | 2019 | 52 |
| 17 | 2022 | 51 | |
| 18 | 2012 | 49 | |
| 19 | 2019 | 46 | |
| 20 | 2021 | 45 |
About Bowen Li
Bowen Li is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Epidemiology and Oncology, having authored 163 papers that have together received 3.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Extracellular vesicles in disease (14 papers), Ubiquitin and proteasome pathways (13 papers), Cancer-related molecular mechanisms research (13 papers), Autophagy in Disease and Therapy (12 papers), RNA modifications and cancer (12 papers), Epigenetics and DNA Methylation (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Cancer Research (767 citations), Molecular Biology (1.8k citations), Immunology (404 citations), Oncology (473 citations) and Microbiology (107 citations). Bowen Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Canhua Huang, Edouard C. Nice, Zhao Huang, Siyuan Qin, Jing Tang, Jingwen Jiang, Zhihan Wang, Mengtong Xu, Hui Ming and Li Zhou. Their work appears in journals such as Small, Cell Death and Disease, Cancer Letters, Drug Resistance Updates and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.